Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition. | JCI Insight | 2023 | 37154160 | PubTator, text mining | PubMed |
| Sexual & reproductive health information on minor consent forms for pubertal suppression and gender affirming hormones. | Front Reprod Health | 2023 | 37152482 | PubTator, text mining | PubMed |
| Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. | EBioMedicine | 2023 | 37146405 | PubTator, text mining | PubMed |
| Tumor-derived exosomal miR-148b-3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion. | Thorac Cancer | 2023 | 37144254 | PubTator, text mining | PubMed |
| Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse. | Sci Adv | 2023 | 37126544 | PubTator, text mining | PubMed |
| mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin. | Sci Rep | 2023 | 37120454 | PubTator, text mining | PubMed |
| Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery. | Pharmaceutics | 2023 | 37111603 | PubTator, text mining | PubMed |
| Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation. | Leukemia | 2023 | 37100883 | PubTator, text mining | PubMed |
| Dysregulated Lymphocyte Antigen Receptor Signaling in Common Variable Immunodeficiency with Granulomatous Lymphocytic Interstitial Lung Disease. | J Clin Immunol | 2023 | 37093407 | PubTator, text mining | PubMed |
| Deciphering the mechanism of PSORI-CM02 in suppressing keratinocyte proliferation through the mTOR/HK2/glycolysis axis. | Front Pharmacol | 2023 | 37089953 | PubTator, text mining | PubMed |
| CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis. | Immunobiology | 2023 | 37086690 | PubTator, text mining | PubMed |
| FERM domain-containing protein FRMD6 activates the mTOR signaling pathway and promotes lung cancer progression. | Front Med | 2023 | 37060526 | PubTator, text mining | PubMed |
| Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. | Blood Cancer J | 2023 | 37055414 | PubTator, text mining | PubMed |
| Assessment of tau phosphorylation and β-amyloid pathology in human drug-resistant epilepsy. | Epilepsia Open | 2023 | 37052232 | PubTator, text mining | PubMed |
| Targeting mTOR for Anti-Aging and Anti-Cancer Therapy. | Molecules | 2023 | 37049920 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens identify ILF3 as a mediator of mTORC1-dependent amino acid sensing. | Nat Cell Biol | 2023 | 37037994 | PubTator, text mining | PubMed |
| Oncogenic signaling is coupled to colorectal cancer cell differentiation state. | J Cell Biol | 2023 | 37017636 | PubTator, text mining | PubMed |
| CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth. | Cell Rep | 2023 | 36995937 | PubTator, text mining | PubMed |
| Targeting mTOR Pathway in PTEN Deleted Newly Isolated Chordoma Cell Line. | J Pers Med | 2023 | 36983607 | PubTator, text mining | PubMed |
| The Role of Genetic, Metabolic, Inflammatory, and Immunologic Mediators in the Progression of Intraductal Papillary Mucinous Neoplasms to Pancreatic Adenocarcinoma. | Cancers (Basel) | 2023 | 36980608 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=11